Establishment Labs Stock (NASDAQ:ESTA)



Previous Close

$30.18

52W Range

$26.56 - $60.12

50D Avg

$36.35

200D Avg

$40.96

Market Cap

$907.20M

Avg Vol (3M)

$604.73K

Beta

0.78

Div Yield

-

ESTA Company Profile


Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CR

Employees

1,018

IPO Date

Jul 19, 2018

Website

ESTA Performance


Revenue Breakdown


Revenue Breakdown by Geography

GeographyDec 24Dec 23Dec 22
Asia Pacific$48.41M$33.95M-
EMEA$78.21M$80.15M-
Latin America$35.00M$48.89M$52.44M
North America$4.41M--
Other Geographical Areas-$2.16M$994.00K
Asia Pacific And Middle East--$59.56M
Europe--$48.70M

Fiscal year ends in Dec 24 | Currency in USD

ESTA Financial Summary


Dec 24Dec 23Dec 22
Revenue$166.03M$165.15M$161.70M
Operating Income$-49.99M$-65.03M$-39.66M
Net Income$-84.60M$-78.50M$-75.21M
EBITDA$-49.99M$-58.31M$-56.90M
Basic EPS$-3.03$-3.07$-3.08
Diluted EPS$-3.03$-3.07$-3.08

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Feb 26, 25 | 4:30 PM
Q3 24Nov 09, 24 | 4:30 PM
Q2 24Aug 06, 24 | 4:30 PM

Peer Comparison


TickerCompany
TMCITreace Medical Concepts, Inc.
LUNGPulmonx Corporation
KIDSOrthoPediatrics Corp.
CNMDCONMED Corporation
INGNInogen, Inc.
FNAParagon 28, Inc.
SGHTSight Sciences, Inc.
NPCENeuroPace, Inc.
APYXApyx Medical Corporation
LIVNLivaNova PLC
GKOSGlaukos Corporation
SRDXSurmodics, Inc.
ITGRInteger Holdings Corporation